MDA Malaysia Medical Device Registration

Under Medical Device Act 2012 (Act 737), Class B, C and D devices require conformity assessment by an MDA-registered CAB before registration through MeDC@St, while Class A devices can be submitted directly to MDA. Devices with eligible approvals from recognized regulatory authorities, may qualify for the faster Verification Route. This includes eligible Class B, C and D devices registered in Singapore's Medical Device Register (SMDR) under the MDA-HSA regulatory reliance programme. Timelines depend on the registration route, device classification, and dossier readiness. Cisema can advise on the appropriate route and support dossier preparation and submission.

Yes. Foreign manufacturers must appoint a Malaysian Authorised Representative (AR), which holds an MDA establishment licence and is responsible for medical device registration. Importers and distributors must also obtain establishment licences. Using an independent AR avoids distributor lock-in. Cisema can act as your independent AR through its Malaysian entity and support establishment licensing and product registration.

The CAB reviews technical documentation in CSDT format, quality system evidence (typically ISO 13485), risk management and clinical evidence. Local clinical trials are generally not required for established devices. For devices with eligible approvals from recognized regulatory authorities may benefit from the Verification Route,which allows an abridged conformity assessment on HSA's evaluation. Cisema can support dossier preparation, CAB submission and assess eligibility for the Verification Route.

A Singapore approval is a key shortcut: MDA continues to accept eligible Class B, C and D devices registered in Singapore's Medical Device Register (SMDR) through its Verification Route following the successful pilot (1 September 2025 to 28 February 2026), with the programme officially continued from 1 March 2026. CE and FDA approvals may also qualify for the Verification Route, subject to MDA's recognition and eligibility criteria. Cisema can sequence Singapore and Malaysia submissions to maximise regulatory reliance.

Medical device registrations are valid for a fixed term (five years) and must be renewed before expiry. The AR and establishment licence holders must comply with PMS requirements, including mandatory incident reporting, FSCA, recalls, complaint handling, and maintaining distribution records. Establishment licences must also be renewed before expiry. Cisema can support post-market compliance, product registration renewals, establishment licence renewals, and vigilance reporting.

MDA allows e-IFU for medical devices intended exclusively for professional users, subject to specific conditions. Users must be able to request a paper copy free of charge, the access details must be provided on the physical label, and manufacturers must conduct and document a risk analysis. For home-use devices, paper-form IFU remains mandatory, while e-IFU may be provided as an additional option. Labelling must also comply with Malaysian language and content requirements. Cisema can review your labelling and IFU strategy as part of the registration process.